Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ATHA | Athira Pharma, Inc. | May 24, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
XOMA | XOMA Corp | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
CERO | PHOENIX BIOTECH ACQUISITION CORP. | Feb 14, 2024 | 1 | $0 | 4 | Feb 16, 2024 | Director |
KRON | Kronos Bio, Inc. | Jan 4, 2024 | 1 | -$12.6K | 4 | Jan 5, 2024 | COO & General Counsel |
ATHA | Athira Pharma, Inc. | May 19, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
XOMA | XOMA Corp | May 17, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
KRON | Kronos Bio, Inc. | Feb 15, 2023 | 2 | $0 | 4 | Feb 17, 2023 | COO & General Counsel |
KRON | Kronos Bio, Inc. | Jul 25, 2022 | 1 | $0 | 4 | Jul 27, 2022 | COO & General Counsel |
ATHA | Athira Pharma, Inc. | May 20, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
XOMA | XOMA Corp | May 18, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
KRON | Kronos Bio, Inc. | Feb 15, 2022 | 2 | $0 | 4 | Feb 17, 2022 | COO & General Counsel |
PBAX | PHOENIX BIOTECH ACQUISITION CORP. | Oct 8, 2021 | 1 | $0 | 4 | Oct 12, 2021 | Director |
PBAX | PHOENIX BIOTECH ACQUISITION CORP. | Oct 5, 2021 | 0 | $0 | 3 | Oct 5, 2021 | Director |
XOMA | XOMA Corp | May 19, 2021 | 1 | $0 | 4 | May 21, 2021 | Director |